Clinical characteristics and outcomes of pediatric patients with CMV DNA detection in bronchoalveolar lavage fluid

Pediatric Pulmonology

Volumn 52, Issue 1, 2017, Pages 112-118

  Burgener, Elizabeth B ^a   Waggoner, Jesse ^a   Pinsky, Benjamin A ^a   Chen, Sharon F ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bronchoalveolar lavage; bronchoscopy; cytomegalovirus; infections: pneumonia; TB; viral

Indexed keywords

IMMUNOGLOBULIN; VALGANCICLOVIR; VIRUS DNA;

ANTIBODY DETECTION; ARTICLE; BONE MARROW TRANSPLANTATION; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CLINICAL ARTICLE; CLINICAL FEATURE; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; COUGHING; CYSTIC FIBROSIS; CYTOMEGALOVIRUS INFECTION; DEMOGRAPHY; DISEASE SEVERITY; DYSPNEA; FORCED EXPIRATORY VOLUME; HEMOPTYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; INSTITUTIONAL REVIEW; LUNG DISEASE; LUNG FUNCTION TEST; MALE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; RHEUMATOLOGY; TACHYPNEA; THORAX RADIOGRAPHY; X-RAY COMPUTED TOMOGRAPHY; ADOLESCENT; CHILD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; INFANT; ISOLATION AND PURIFICATION; NEWBORN; PRESCHOOL CHILD; VIROLOGY;

ADOLESCENT; BRONCHOALVEOLAR LAVAGE FLUID; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; POLYMERASE CHAIN REACTION;

EID: 84978647046     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.23494     Document Type: Article

References (30)

1. Bate SL, Dollard SC, Cannon MJ. Cytomegalovirus Seroprevalence in the United States: the National Health and Nutrition Examination Surveys, 1988–2004. Clin Infect Dis 2010; 50:1439–1447.
2. Travi G, Pergam SA. Cytomegalovirus pneumonia in hematopoietic stem cell recipients. J Intensive Care Med 2013; 29:200–212.
3. Boeckh M, Nichols WG, Papanicolaou G, Rubin R, Wingard JR, Zaia J. Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies. Biol Blood Marrow Transplant 2003; 9:543–558.
4. Konoplev S, Champlin RE, Giralt S, Ueno NT, Khouri I, Raad I, Rolston K, Jacobson K, Tarrand J, Luna M, et al. Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients. Bone Marrow Transplant 2001; 27:877–881.
5. Kalil AC, Levitsky J, Lyden E, Stoner J, Freifeld AG. Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Ann Intern Med 2005; 143:870–880.
6. Chmiel C, Speich R, Hofer M, Michel D, Mertens T, Weder W, Boehler A. Ganciclovir/valganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation. Clin Infect Dis 2008; 46:831–839.
7. Ruttmann E, Geltner C, Bucher B, Ulmer H, Höfer D, Hangler HB, Semsroth S, Margreiter R, Laufer G, Müller LC. Combined CMV prophylaxis improves outcome and reduces the risk for bronchiolitis obliterans syndrome (BOS) after lung transplantation. Transplantation 2006; 81:1415–1420.
8. Danziger-Isakov LA, Worley S, Michaels MG, Arrigain S, Aurora P, Ballmann M, Boyer D, Conrad C, Eichler I, Elidemir O, et al. The risk, prevention, and outcome of cytomegalovirus after pediatric lung transplantation. Transplantation 2009; 87:1541–1548.
9. Chemaly RF, Yen-Lieberman B, Chapman J, Reilly A, Bekele BN, Gordon SM, Procop GW, Shrestha N, Isada CM, Decamp M, et al. Clinical utility of cytomegalovirus viral load in bronchoalveolar lavage in lung transplant recipients. Am J Transplant 2005; 5:544–548.
10. Millar AB, Patou G, Miller RF, Grundy JE, Katz DR, Weller IV, Semple SJ. Cytomegalovirus in the lungs of patients with AIDS: respiratory pathogen or passenger? Ame Rev Respir Dis 1990; 141:1474–1477.
11. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002; 34:1094–1097.
12. Snyder LD, Finlen-Copeland CA, Turbyfill WJ, Howell D, Willner DA, Palmer SM. Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation. Am J Respir Crit Care Med 2010; 181:1391–1396.
13. Nguyen Q, Estey E, Raad I, Rolston K, Kantarjian H, Jacobson K, Konoplev S, Ghosh S, Luna M, Tarrand J, et al. Cytomegalovirus pneumonia in adults with leukemia: an emerging problem. Clin Infect Dis 2001; 32:539–545.
14. Waggoner JJ, Pinsky BA. Comparison of automated nucleic acid extraction methods for the detection of cytomegalovirus DNA in fluids and tissues. PeerJ 2014; 2:e334.
15. Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Danziger-Isakov L, Humar A. Group on behalf of TTSICC. updated international consensus guidelines on the management of cytomegalovirus in solid-Organ transplantation. [Editorial]. Transplantation 2013; 96:333–360.
16. Ettinger NA, Bailey TC, Trulock EP, Storch GA, Anderson D, Raab S, Spitznagel EL, Dresler C, Cooper JD. Cytomegalovirus infection and pneumonitis: impact after isolated lung transplantation. Am Rev Respir Dis 1993; 147:1017–1023.
17. Simon CO, Seckert CK, Dreis D, Reddehase MJ, Grzimek NKA. Role for tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs. J Virol 2005; 79:326–340.
18. Döcke WD, Fietze E, Syrbe U, von Baehr R, Volk HD, Prösch S, Kimel V, Krüger DH, Zuckermann H, Klug C. Cytomegalovirus reactivation and tumour necrosis factor. Lancet 1994; 343:268–269. (Originally published as Volume 1, Issue 8892).
19. Westall GP, Michaelides A, Williams TJ, Snell GI, Kotsimbos TC. Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients. J Infect Dis 2004; 190:1076–1083.
20. Kerschner H, Jaksch P, Karigl G, Popow-Kraupp T, Klepetko W, Puchhammer-Stockl E. Cytomegalovirus DNA load patterns developing after lung transplantation are significantly correlated with long-Term patient survival. Transplantation 2009; 87:1720–1726.
21. Ruutu P, Ruutu T, Volin L, Tukiainen P, Ukkonen P, Hovi T. Cytomegalovirus is frequently isolated in bronchoalveolar lavage fluid of bone marrow transplant recipients without pneumonia. Ann Intern Med 1990; 112:913–916.
22. Schmidt GM, Horak DA, Niland JC, Duncan SR, Forman SJ, Zaia JA. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. N Engl J Med 1991; 324:1005–1011.
23. Just-Released National Data Confirm Lucile Packard Children's Hospital Stanford No. 1 in Transplantation. Business Wire. 2015 Mar 26 [accessed 2015 Apr 11]. http://www.businesswire.com/news/home/20150326005019/en/Just-Released-National-Data-Confirm-Lucile-Packard-Children%E2%80%99s#.VSh9U0ZFCx0.
24. Lucile Packard Children's Hospital at Stanford. BMT InfoNet. [accessed 2015 Apr 11]. http://www.bmtinfonet.org/node/6840.
25. Pediatric Health Information Systems (PHIS) Database. Children's Hospital Association. [accessed 2014 Sep 30]. https://www.childrenshospitals.org/.
26. Restrepo-Gualteros SM, Jaramillo-Barberi LE, Gonzalez-Santos M, Rodriguez-Martinez CE, Perez GF, Gutierrez MJ, Nino G. Characterization of cytomegalovirus lung infection in non-HIV infected children. Viruses 2014; 6:2038–2051.
27. Chiche L, Forel J-M, Roch A, Guervilly C, Pauly V, Allardet-Servent J, Gainnier M, Zandotti C, Papazian L. Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients. Crit Care Med 2009; 37:1850–1857.
28. Tan SK, Burgener EB, Waggoner JJ, Gajurel K, Gonzalez S, Chen SF, Pinsky BA. Molecular and culture-Based bronchoalveolar lavage fluid testing for the diagnosis of cytomegalovirus pneumonitis. Open Forum Infect Dis 2016; 3:ofv212.
29. Green ML, Leisenring W, Stachel D, Pergam SA, Sandmaier BM, Wald A, Corey L, Boeckh M. Efficacy of a viral load-based, risk-adapted, preemptive treatment strategy for prevention of Cytomegalovirus disease after hematopoietic cell transplantation. Biol Blood Marrow Trans 2012; 18:1687–1699.
30. Weseslindtner L, Görzer I, Küng E, Roedl K, Jaksch P, Klepetko WP, uchhammer-Stöckl E. High CXCL-16 levels correlate with symptomatic disease in lung transplant recipients with human cytomegalovirus replication in the allograft. Am J Transplant 2014; 14:2406–2411.